Publication | Closed Access

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineFolfox Versus FluorouracilCancer TreatmentOesophageal CancerOncologyRadiation OncologyDefinitive ChemoradiotherapyRadiologyHealth Sciences